Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001937147-24-000008
Filing Date
2024-09-11
Accepted
2024-09-11 16:04:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 cldi.htm SC 13G 102254
  Complete submission text file 0001937147-24-000008.txt   103983
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92875 | Film No.: 241292613
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Funds, LP (Filed by) CIK: 0001937147 (see all company filings)

EIN.: 882460308 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G